Cardiac Events with Gleevec

Armen Hareyan's picture

Novartis is notifying healthcare professionals about new precautions for Gleevec (imatinib mesylate). Gleevec is used to treat certain patients with chronic myeloid leukemia and gastrointestinal stromal tumors.

A recent article published in Nature Medicine reported on ten patients taking Gleevec who developed severe congestive heart failure and left ventricular dysfunction. Before starting treatment, most of these patients had

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.